Delivery Order SPE2DB22D2007-SPE2DB25FJ4NY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,276.16 to AmerisourceBergen Drug Corp for 1,000 tablets of Losartan Potassium 100 mg, a commonly prescribed antihypertensive medication. The contract, executed on July 28, 2025, with an ultimate completion date of July 29, 2025, utilizes firm fixed-price terms and requires performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award includes no set-aside designation and was competitively awarded through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Losartan Potassium 100 mg tablets in quantities of 1,000 units, with a ceiling value of $1,663.10. This firm fixed-price delivery order is set to be completed by July 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was awarded competitively without set-aside provisions, reflecting AmerisourceBergen's capability to meet...
- The Defense Logistics Agency awarded a delivery order valued at $2,182.31 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Losartan Potassium 100 mg. This non-set-aside, competitively awarded contract features firm fixed pricing and was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Losartan Potassium 50 mg tablets in quantities of 1,000 units, with a contract ceiling value of $1,151.65. This is a firm fixed price delivery order with an ultimate completion date of August 21, 2025. The award was not set-aside and represents a competitively awarded transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Losartan Potassium 100 mg tablets in quantities of 1,000 units. Valued at $1,016.18 with firm fixed pricing, this non-set-aside delivery order is scheduled for completion by August 20, 2025, with performance occurring at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,072.76 on July 28, 2025, for the supply of Losartan Potassium 25 mg tablets in quantities of 1,000 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 29, 2025, with performance occurring at the vendor's facility in Conshohocken, Pennsylvania. The award represents a small-value transaction typical of routine pharmaceutical procurement operations supporting...
- The Defense Logistics Agency awarded a delivery order valued at $1,084.59 to AmerisourceBergen Drug Corp for the supply of Losartan Potassium 25 mg tablets in quantities of 1,000 units. This order, which was competitively awarded without a set-aside designation, represents a firm fixed-price delivery under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The product will be delivered to AmerisourceBergen's Conshohocken, Pennsylvania location, with an...
- This is a $7,783.36 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,560,665,986 units of Losartan Potassium 100 mg tablets in 1,000-count sizes, with a completion date of April 21, 2023. This award is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract with the DLA Troop Support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,563,081,045 units of Losartan Potassium 100 mg tablets in 1,000-count bottles, with a ceiling value of $9,482.89. The contract is a Firm Fixed Price delivery order with a completion date of December 13, 2023. AmerisourceBergen holds a larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of 1,000 tablets of Losartan Potassium 50 mg at a ceiling value of $1,120.32. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 5, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation and is classified as a child contract under a larger vehicle. This...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4NYDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of 1,000 tablets of Losartan Potassium 100 mg, valued at $3,470.22. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by September 4, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Losartan potassium is a generic antihypertensive medication commonly used in military and veteran healthcare systems to manage hypertension. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains an extensive portfolio of contracts with DLA and other government healthcare systems, delivering medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency operations and other federal health programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 9/3/25 |